Sorry, you need to enable JavaScript to visit this website.

CYKLOKAPRON® (tranexamic acid) Indications and Usage

1 INDICATIONS AND USAGE

CYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for CYKLOKAPRON®